A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection

Clinical trial NCT06903338 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06903338
Sponsor: Vir Biotechnology, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Viral Hepatitis

Start date: 2025-03-12
Primary completion: 2026-12-31
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.